Michael Gelband’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
36,789
+17,114
+87% +$114K ﹤0.01% 1346
2026
Q1
$107K Sell
19,675
-72,865
-79% -$409K ﹤0.01% 1433
2025
Q4
$648K Buy
92,540
+48,060
+108% +$376K 0.01% 1124
2025
Q3
$344K Buy
+44,480
New +$347K ﹤0.01% 1270
2025
Q2
Sell
-70,837
Closed -$564K 1965
2025
Q1
$564K Buy
+70,837
New +$717K 0.01% 1084
2024
Q2
Sell
-56,135
Closed -$848K 1975
2024
Q1
$848K Sell
56,135
-278,551
-83% -$5.05M 0.01% 1000
2023
Q4
$7.21M Sell
334,686
-45,740
-12% -$844K 0.05% 267
2023
Q3
$7.07M Buy
380,426
+169,576
+80% +$3.96M 0.07% 297
2023
Q2
$5.34M Sell
210,850
-52,232
-20% -$1.31M 0.04% 429
2023
Q1
$6.81M Buy
263,082
+97,815
+59% +$2.62M 0.06% 408
2022
Q4
$3.91M Buy
165,267
+76,303
+86% +$2.06M 0.06% 417
2022
Q3
$2.25M Buy
88,964
+52,330
+143% +$1.84M 0.03% 751
2022
Q2
$1.22M Buy
36,634
+21,777
+147% +$925K 0.01% 993
2022
Q1
$1.07M Buy
14,857
+429
+3% +$30.9K 0.01% 1102
2021
Q4
$1.32M Buy
+14,428
New +$1.72M 0.01% 936
2021
Q1
Sell
-3,053
Closed -$610K 2594
2020
Q4
$610K Sell
3,053
-3,868
-56% -$787K 0.01% 1126
2020
Q3
$1.52M Sell
6,921
-7,186
-51% -$1.52M 0.03% 498
2020
Q2
$2.69M Buy
14,107
+12,027
+578% +$2.11M 0.07% 322
2020
Q1
$322K Sell
2,080
-34,802
-94% -$4.05M 0.02% 635
2019
Q4
$3.09M Buy
+36,882
New +$2.81M 0.06% 243
2019
Q1
Sell
-8,990
Closed -$446K 768
2018
Q4
$446K Buy
+8,990
New +$550K 0.03% 162

Other funds holding TDOC

Michael Gelband's TDOC Position: Q2 2026 in Review

Michael Gelband increased its Teladoc Health (TDOC) stake by 87% in Q2 2026, buying an estimated $114K and bringing the position to 36,789 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

Michael Gelband first reported a position in TDOC in Q4 2018 and has held it in 21 quarters since. The position peaked at $7.21M in Q4 2023. 345 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Michael Gelband held 36,789 shares of Teladoc Health worth $312K as of Q2 2026.
  • Michael Gelband bought 17,114 Teladoc Health shares in Q2 2026, an estimated $114K.
  • Teladoc Health made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1346 holding.
  • Michael Gelband first reported a position in Teladoc Health in Q4 2018 and has held it in 21 quarters since.
  • Michael Gelband's Teladoc Health position peaked at $7.21M in Q4 2023.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.